Susan Smith
Fortuna: 2 759 $ al 31/05/2026
Fortuna: 2 759 $ al 31/05/2026
Susan Smith is currently the Chief Executive Officer at The Portland Hospital For Women & Children.
She is also the Vice Chairman at Clinuvel Pharmaceuticals Ltd., the Chairman at Evewell Group Ltd., and the Director at HCA Hope Fund.
Previously, she held the position of Chief Executive Officer at The Princess Grace Hospital and The Independent Doctors Federation.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 420 ( 0 % ) | 2 759 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director/Miembro de la Junta | 23/09/2019 |
Evewell Group Ltd. | Presidente | - |
HCA Hope Fund | Director/Miembro de la Junta | - |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
The Princess Grace Hospital | Director Ejecutivo | - |
The Independent Doctors Federation | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The Princess Grace Hospital | |
HCA Hope Fund | |
The Independent Doctors Federation | |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Evewell Group Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.